BACTRIM (Echo Therapeutics Pty Ltd)
Product name
BACTRIM
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
144 (255 working days)
Active ingredients
Sulfamethoxazole, Trimethoprim
Registration type
New generic medicine
Indication
Parenteral administration of BACTRIM is indicated where oral dosage is not desirable or practical, e.g. pre- and post-operative infections associated with surgery, trauma or gynaecology; septicaemia and other infections due to sensitive organisms such as typhoid and paratyphoid.
Registration process
First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine